Podrobno

A 15-year experience highlighting the spectrum of Alport kidney disease in the pediatric population and novel genetic variants in COL4A3–5
ID Andrejašič, Nastja (Avtor), ID Blejc Novak, Anja (Avtor), ID Močnik, Mirjam (Avtor), ID Marčun-Varda, Nataša (Avtor), ID Stangler Herodež, Špela (Avtor), ID Krgović, Danijela (Avtor), ID Zupan, Andrej (Avtor), ID Meglič, Anamarija (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (896,33 KB)
MD5: CE10BF298A881D70746F3D25A873B58E
URLURL - Izvorni URL, za dostop obiščite https://link.springer.com/article/10.1007/s00467-025-06683-8 Povezava se odpre v novem oknu

Izvleček
Background Alport kidney disease (AKD) presents one of the most prevalent genetic kidney disorders, characterized by a complex genetic background and diverse clinical manifestations. This study aimed to review the clinical and genetic features of pediatric patients with COL4A3–5 variants and identify novel genetic variants. Methods Data were collected retrospectively at a national level from pediatric patients up to 19 years old, who underwent genetic testing between 2008 and 2023. Patients with pathogenic and likely pathogenic COL4A3–5 variants were included. Their clinical, laboratory, and genetic characteristics were presented. Results Over 15 years, 85 children and adolescents tested positive for pathogenic or likely pathogenic COL4A3–5 variants. Increasing incidence was noted as genetic testing became more prevalent. One patient (1.2%) progressed to kidney failure and six (7%) had extrarenal involvement. Pathogenic or likely pathogenic variants in COL4A3, COL4A4, and COL4A5 genes were found in 14 (16.4%), 34 (40.0%), and 37 (43.6%) patients, respectively. Patients were diagnosed with autosomal, X-linked, and digenic AKD in 55.2%, 43.6%, and 1.2%, respectively. Eight novel variants were recorded, and their associated phenotype presented. Conclusions This study expands the genetic and clinical background of pediatric patients with AKD, presenting on a spectrum from mild hematuria to progressive chronic kidney disease. Genetic confirmation and risk stratification in the pediatric population are critical to ensure timely care and potentially slow down the progression of kidney disease.

Jezik:Angleški jezik
Ključne besede:Alport kidney disease, children, phenotype, genotype, COL4A3–5, hereditary nephritis, kidney diseases
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2025
Št. strani:Str. 2215–2223
Številčenje:Vol. 40, iss. 7
PID:20.500.12556/RUL-169429 Povezava se odpre v novem oknu
UDK:616.6
ISSN pri članku:1432-198X
DOI:10.1007/s00467-025-06683-8 Povezava se odpre v novem oknu
COBISS.SI-ID:225255171 Povezava se odpre v novem oknu
Datum objave v RUL:28.05.2025
Število ogledov:314
Število prenosov:52
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Pediatric nephrology
Skrajšan naslov:Pediatr. nephrol.
Založnik:Springer Nature
ISSN:1432-198X
COBISS.SI-ID:513718041 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Projekti

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P3-0054
Naslov:Patologija in molekularna genetika

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj